The 2022 National Drug Control Strategy released by the White House yesterday would expand substance use prevention and early intervention strategies and enable physicians to more effectively provide treatment to patients with substance use disorder (SUD). SUD is a treatable chronic medical condition, like diabetes and hypertension, but access to care for this disorder is limited.
The American College of Physicians (ACP) is glad to see that the White House’s strategy would evaluate reimbursement policies for treatments, remove barriers to buprenorphine prescribing, and develop addiction curriculum for medical schools. It also promotes proven harm reduction strategies like expanded access to naloxone. ACP also supports the administration’s call for reforms in related criminal justice policies. This includes promoting alternatives to incarceration and identifying racial inequities in investigation, arrest, and sentencing data and using that to drive policy change.
Source: Read Full Article